Cochrane Abstracts
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) for Assessing Tumour Resectability in Advanced Epithelial Ovarian/fallopian Tube/primary Peritoneal Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer.
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer. Accessed February 16, 2025.
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer
Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) for Assessing Tumour Resectability in Advanced Epithelial Ovarian/fallopian Tube/primary Peritoneal Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer
ID - 435687
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/Positron_emission_tomography__PET__and_magnetic_resonance_imaging__MRI__for_assessing_tumour_resectability_in_advanced_epithelial_ovarian_fallopian_tube_primary_peritoneal_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
